Allergan (AGN) FCF conversion US GAAP (year values) |
|||||||||
| FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | LTM ? | 5 years average | |||
| FCF conversion, % | 43.5% | 5.31% | -245.7% | 679.5% | 399.3% | 211.3% | |||
| Changes by years, y/y, % | -88pp | -38pp | -251pp | +925pp | -280pp | +176% | |||
Allergan. FCF conversion, %
Allergan. FCF conversion, changes, pp
Allergan (AGN) FCF conversion US GAAP (quarter values) |
||||||||
| FY2019Q1 | FY2019Q2 | FY2019Q3 | FY2019Q4 | FY2020Q1 | LTM ? | |||
| FCF conversion, % | -141.2% | 686.1% | 277.5% | 115.4% | 33.0% | 211.3% | ||
| Changes by years, y/y, % | -278pp | +607pp | +209pp | +153pp | +174pp | |||
| Changes by quarters, q/q, % | -104pp | +827pp | -409pp | -162pp | -82pp | |||